Triangle Laboratory Launches Bioanalytical Services to COVID-19 Projects

June 24, 2020

Triangle Laboratory, a leading bioanalytical testing laboratory specializing in ligand binding and cell-based assays, announced today the bioanalytical service to COVID-19 related studies.

Dr. Liu, Head of Bioanalysis at Triangle Laboratory said: “To support the development of therapeutics to COVID-19, we start to offer PK, biomarker and ADA bioanalytical service in our BSL-2 laboratory. We have developed virus deactivation procedure in bioanalytical assays, which has no impact to bioanalytical data. To speed up the COVID program, we offer one-month method development and validation and provide 48 hours turnaround timeline in sample analysis. We commit to support our sponsor and contribute to human health.

About Triangle Laboratory

Triangle Laboratory Inc., a contract research organization (CRO), is a leading bioanalytical laboratory for large molecule bioanalysis. Triangle Laboratory provides TK/PK, ADA, NAb, Biomarker and functional assay services for supporting the development of biologics. Headquartered in Delaware Industrial Park, Triangle Laboratory supports method development, method qualification/validation, and sample analysis under both non-GLP and GLP.

Speak to Our Team